Related Content
Search Google Scholar for:
|
|
Science 18 November 1983: Vol. 222. no. 4625, pp. 765 - 771 DOI: 10.1126/science.6356357
|
|
Articles
Science, Vol 222, Issue 4625, 765-771
Copyright © 1983 by American Association for the Advancement of Science
Translocations among antibody genes in human cancer
P Leder,
J Battey,
G Lenoir,
C Moulding,
W Murphy,
H Potter,
T Stewart,
and
R Taub
The characteristic chromosomal translocations that occur in certain human malignancies offer opportunities to understand how two gene systems can affect one another when they are accidentally juxtaposed. In the case of Burkitt lymphoma, such a translocation joins the cellular oncogene, c-myc, to a region encoding one of the immunoglobulin genes. In at least one example, the coding sequence of the rearranged c-myc gene is identical to that of the normal gene, implying that the gene must be quantitatively, rather than qualitatively, altered in its expression if it is to play a role in transformation. One might expect to find the rearranged c-myc gene in a configuration that would allow it to take advantage of one of the known immunoglobulin promoters or enhancer elements. However, the rearranged c-myc gene is often placed so that it can utilize neither of these structures. Since the level of c-myc messenger RNA is often elevated in Burkitt cells, the translocation may lead to a deregulation of the c-myc gene. Further, since the normal allele in a Burkitt cell is often transcriptionally silent in the presence of a rearranged allele, a model for c-myc regulation is suggested that involves a trans-acting negative control element that might use as its target a highly conserved portion of the c-myc gene encoding two discrete transcriptional promoters.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.
- M. A. Shammas, R. J. Shmookler Reis, H. Koley, R. B. Batchu, C. Li, and N. C. Munshi (2009)
Blood
113, 2290-2297
| Abstract »
| Full Text »
| PDF »
- Epstein-Barr Virus Nuclear Antigen 3C Interacts with and Enhances the Stability of the c-Myc Oncoprotein.
- B. G. Bajaj, M. Murakami, Q. Cai, S. C. Verma, K. Lan, and E. S. Robertson (2008)
J. Virol.
82, 4082-4090
| Abstract »
| Full Text »
| PDF »
- Epstein-Barr Virus and Cancer.
- M. P. Thompson and R. Kurzrock (2004)
Clin. Cancer Res.
10, 803-821
| Abstract »
| Full Text »
| PDF »
- Repression of c-myc Is Necessary but Not Sufficient for Terminal Differentiation of B Lymphocytes In Vitro.
- K.-I Lin, Y. Lin, and K. Calame (2000)
Mol. Cell. Biol.
20, 8684-8695
| Abstract »
| Full Text »
- Lymphocytes.
- L. G. Israels and E. D. Israels (1999)
Oncologist
4, 129-137
| Abstract »
| Full Text »
- A Novel Intron Element Operates Posttranscriptionally To Regulate Human N-myc Expression.
- L. E. Sivak, G. Pont-Kingdon, K. Le, G. Mayr, K.-F. Tai, B. T. Stevens, and W. L. Carroll (1999)
Mol. Cell. Biol.
19, 155-163
| Abstract »
| Full Text »
| PDF »
- Constitutive and Interleukin-7/Interleukin-15 Stimulated DNA Binding of Myc, Jun, and Novel Myc-Like Proteins in Cutaneous T-Cell Lymphoma Cells.
- J-Z. Qin, R. Dummer, G. Burg, and U. Dobbeling (1999)
Blood
93, 260-267
| Abstract »
| Full Text »
| PDF »
- Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Translocations and Chromosomal Aberrations in Acute Leukemia.
- N. Pallisgaard, P. Hokland, D. C. Riishoj, B. Pedersen, and P. Jorgensen (1998)
Blood
92, 574-588
| Abstract »
| Full Text »
| PDF »
- Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia.
- P Liu, S. Tarle, A Hajra, D. Claxton, P Marlton, M Freedman, M. Siciliano, and F. Collins (1993)
Science
261, 1041-1044
| Abstract »
| PDF »
- Chromosome aberrations and cancer.
- E Solomon, J Borrow, and A. Goddard (1991)
Science
254, 1153-1160
| Abstract »
| PDF »
- New light on Myc and Myb. Part I. Myc..
- B Luscher and R N Eisenman (1990)
Genes & Dev.
4, 2025-2035
| PDF »
- Normal expression of a rearranged and mutated c-myc oncogene after transfection into fibroblasts.
- A Richman and A Hayday (1989)
Science
246, 494-497
| Abstract »
| PDF »
- Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma.
- E Cesarman, R Dalla-Favera, D Bentley, and M Groudine (1987)
Science
238, 1272-1275
| Abstract »
| PDF »
- Syndromes of Acute Nonlymphocytic Leukemia.
- H. P. KOEFFLER (1987)
Ann Intern Med
107, 748-758
| Abstract »
| PDF »
- Disease diagnosis by recombinant DNA methods.
- C. Caskey (1987)
Science
236, 1223-1229
| Abstract »
| PDF »
- Genetic rearrangements and gene amplification in Escherichia coli: DNA sequences at the junctures of amplified gene fusions..
- S K Whoriskey, V H Nghiem, P M Leong, J M Masson, and J H Miller (1987)
Genes & Dev.
1, 227-237
| Abstract »
| PDF »
- The molecular genetics of cancer.
- J. Bishop (1987)
Science
235, 305-311
| Abstract »
| PDF »
- Gene amplification of c-myc and N-myc in small cell carcinoma of the lung.
- A. Wong, J. Ruppert, J Eggleston, Hamilton SR, S. Baylin, and B Vogelstein (1986)
Science
233, 461-464
| Abstract »
| PDF »
- Molecular Genetics of Human B- and T-cell Neoplasia.
- C.M. Croce, J. Erikson, F.G. Haluska, L.R. Finger, L.C. Showe, and Y. Tsujimoto (1986)
Cold Spring Harb Symp Quant Biol
51, 891-898
| Abstract »
| PDF »
- Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis.
- M Linial, N Gunderson, and M Groudine (1985)
Science
230, 1126-1132
| Abstract »
| PDF »
- The action of oncogenes in the cytoplasm and nucleus.
- R. Weinberg (1985)
Science
230, 770-776
| Abstract »
| PDF »
- Chronic Lymphocytic Leukemia: Recent Advances in Biology and Treatment.
- R. P. GALE and K. A. FOON (1985)
Ann Intern Med
103, 101-120
| Abstract »
| PDF »
- Microinjected c-myc as a competence factor.
- L Kaczmarek, J. Hyland, R Watt, M Rosenberg, and R Baserga (1985)
Science
228, 1313-1315
| Abstract »
| PDF »
- Activated proto-onc genes: sufficient or necessary for cancer?.
- P. Duesberg (1985)
Science
228, 669-677
| Abstract »
| PDF »
- Molecular Genetic Analysis of Human Lymphoid Neoplasms: Immunoglobulin Genes and the c-myc Oncogene.
- T. A. WALDMANN, S. J. KORSMEYER, A. BAKHSHI, A. ARNOLD, and I. R. KIRSCH (1985)
Ann Intern Med
102, 497-510
| Abstract »
| PDF »
- Coexpression of translocated and normal c-myc oncogenes in hybrids between Daudi and lymphoblastoid cells.
- C. Croce, J Erikson, K Huebner, and K Nishikura (1985)
Science
227, 1235-1238
| Abstract »
| PDF »
- Location of the c-yes gene on the human chromosome and its expression in various tissues.
- K Semba, Y Yamanashi, M Nishizawa, J Sukegawa, M Yoshida, M Sasaki, T Yamamoto, and K Toyoshima (1985)
Science
227, 1038-1040
| Abstract »
| PDF »
- B-Cell Abnormalities in Multiple Sclerosis: A Hypothesis.
- R. P. Roos (1985)
Arch Neurol
42, 73-75
| Abstract »
| PDF »
- Transcription and promoter usage of the myc gene in normal somatic and spermatogenic cells.
- T. Stewart, A. Bellve, and P Leder (1984)
Science
226, 707-710
| Abstract »
| PDF »
- Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation.
- H Persson, L Hennighausen, R Taub, W DeGrado, and P Leder (1984)
Science
225, 687-693
| Abstract »
| PDF »
- Oncogenes: Implications for the Diagnosis and Treatment of Cancer.
- M. J. CLINE, D. J. SLAMON, and J. S. LIPSICK (1984)
Ann Intern Med
101, 223-233
| Abstract »
| PDF »
- What do oncogenes do?.
- J. Marx (1984)
Science
223, 673-674
| PDF »
- Cellular oncogenes and multistep carcinogenesis.
- H Land, L. Parada, and R. Weinberg (1983)
Science
222, 771-778
| Abstract »
| PDF »
- MM-1, a c-Myc-binding Protein, Is a Candidate for a Tumor Suppressor in Leukemia/Lymphoma and Tongue Cancer.
- Y. Fujioka, T. Taira, Y. Maeda, S. Tanaka, H. Nishihara, S. M. M. Iguchi-Ariga, K. Nagashima, and H. Ariga (2001)
J. Biol. Chem.
276, 45137-45144
| Abstract »
| Full Text »
| PDF »
|
|